FGFR3融合体内异种移植模型平台 - Crown Bioscience

作者：Crown Bioscience | Sep 7, 2018 4:00:00 AM

Our FGFR3 fusion in vivo xenograft platform covering both patient and cell line derived xenografts over a range of cancer types, to advance preclinical FGFR inhibitor development.

查看完整帖子